LakeShore Biopharma Co., Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LSBCF research report →
About the company
LakeShore Biopharma Co. , Ltd (LSBCF) is a biopharmaceutical firm dedicated to the end-to-end process of bringing innovative medical solutions to market. Its primary focus lies in creating vaccines and advanced therapeutic biologics, specifically designed to combat infectious diseases and various forms of cancer.
- CEO
- Wang Xu
- IPO
- 2021
- Employees
- 758
- HQ
- Beijing, CN
Price Chart
- Market Cap
- $2.76M
- P/E
- -0.48
- P/S
- 0.03
- P/B
- 0.10
- EV/EBITDA
- -8.34
- Div Yield
- 0.00%
- Gross Margin
- 82.47%
- Op Margin
- -14.03%
- Net Margin
- -16.26%
- ROE
- -18.43%
- ROIC
- -9.15%
- Revenue
- $614.96M · 7.24%
- Net Income
- $-99,982,451 · 76.93%
- EPS
- $-0.94 · 76.79%
- Op Income
- $-86,291,884
- FCF YoY
- 59.10%
- 52W High
- $1.48
- 52W Low
- $0.03
- 50D MA
- $0.06
- 200D MA
- $0.43
- Beta
- 1.01
- Avg Volume
- 4.00K
Get TickerSpark's AI analysis on LSBCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our LSBCF coverage
Recent articles, reports, and earnings notes.
No research on LSBCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LSBCF report →Similar companies
Peers in the same neighborhood.